| Metric | FY 2026 | FY 2025 |
|---|---|---|
| Revenue | 1,863.0 | 1,824.0 |
| Gross profit | 601.0 | 549.0 |
| Profit before tax | 69.0 | -809.0 |
| Net income | 4.0 | -845.0 |
| EPS (diluted, $ a share) | $0.09 | $-18.23 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +2.1% |
|---|---|
| Gross margin | 32.3% |
| Operating margin | 5.6% |
10-K filed with the SEC, NYSE: ASH. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Ashland Inc.: key numbers
- Share price
- $72.40Close, Nov 20
- Market cap
- $3.4B
- Shares outstanding
- 45.83MLatest SEC cover page
- Sector
- Trade & Services
- Industry
- Wholesale-Chemicals & Allied ProductsSIC 5160
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Ashland Inc.
All →Ashland Financial Results
Ashland Inc. reported fourth quarter fiscal 2026 sales of $498 million, a 4% increase year-over-year driven by volume growth in Life Sciences and Personal Care. The company reported a net loss of $16 million for the quarter but generated $121 million in Adjusted EBITDA and $74 million in ongoing free cash flow.
- Term
- Q4 2026
“Ashland closed fiscal 2026 with strong commercial performance across our higher-growth Life Sciences and Personal Care businesses, as well as coatings and performance specialties within Specialty Additives, and improved profitability in Intermediates.”
Guillermo Novo, chair and chief executive officer, Ashland
“Our priorities are clear: improve operating performance, drive productivity across our network, maintain pricing discipline, build on our commercial momentum and continue to scale our globalize and innovate initiatives.”
Guillermo Novo, chair and chief executive officer, Ashland
Ashland Debt Financing Update with Bank of America, N.A.
Ashland Inc. entered into a Deed of Amendment and Restatement to its European accounts receivable securitization program (EU A/R Facility), extending the scheduled termination date to September 21, 2029. The facility maintains an aggregate limit of €125 million and involves the revolving sale of eligible trade receivables to a bankruptcy-remote subsidiary.
- Counterparty
- Bank of America, N.A.
- Term
- through Sep 2029